3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
8
Polycystic Ovary Syndrome
7
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
6
Colorectal Neoplasms
5
Lung Neoplasms
4
Metabolic Syndrome
3
Insulin Resistance
3
Adenocarcinoma of Lung
3
Lymphoma, Large B-Cell, Diffuse
2
Glioblastoma
2
Carcinoma, Renal Cell
2
pCR Rate
1
Weight Gain
1
Thyroid Diseases
1
Thoracic Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Motor Activity
1
Melanoma
1
Lymphoma
1
Leukoplakia
1
Leukemia, Myelomonocytic, Acute
1
Interventions
Gemcitabine
8
Capecitabine
6
pembrolizumab
5
Carboplatin
5
Pemetrexed
3
Paclitaxel
3
Oxaliplatin
3
Irinotecan
3
regorafenib
2
osimertinib
2
Taxes
2
Sunitinib
2
Radiotherapy
2
Fluorouracil
2
Cisplatin
2
130-nm albumin-bound paclitaxel
2
trifluridine tipiracil drug combination
1
tislelizumab
1
tegafur-gimeracil-oteracil
1
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
sintilimab
1
seribantumab
1
selinexor
1
ruxolitinib
1
rubitecan
1
pralsetinib
1
palbociclib
1
olaparib
1
niraparib
1
linifanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Adenocarcinoma
×
Metformin
×
Clear all
NCT02473094
2017-11-28
NEOMETRE
University of Campinas, Brazil
Phase 2
Terminated
3 enrolled